🇺🇸 FDA
Pipeline program

Zimberelimab

HCC 21-150

Phase 2 small_molecule active

Quick answer

Zimberelimab for Melanoma is a Phase 2 program (small_molecule) at Arcus Biosciences with 1 ClinicalTrials.gov record(s).

Program details

Company
Arcus Biosciences
Indication
Melanoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials